2012
DOI: 10.14200/jrm.2012.1.1001
|View full text |Cite
|
Sign up to set email alerts
|

Vitamin D and Major Chronic Illness

Abstract: OBJECTIVE To review the current literature regarding vitamin D insufficiency and supplementation in major illnesses. DESIGN AND METHODS We reviewed Pubmed-indexed, English language manuscripts from January, 2003 to June, 2012 using search terms related to vitamin D, all-cause mortality, cardiovascular disease, pulmonary disease, diabetes mellitus, and cancer. OUTCOME MEASURES Incidence of disease, risk ratios associated with 25-hydroxyvitamin D [25(OH)D] levels, and/or vitamin D supplementation schedules w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
6
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
5

Relationship

3
2

Authors

Journals

citations
Cited by 5 publications
(6 citation statements)
references
References 122 publications
(151 reference statements)
0
6
0
Order By: Relevance
“…38 Although this traditional delineation is based on bone health–related studies demonstrating maximal parathyroid hormone suppression at 25(OH)D levels around 30 ng/mL, 39 some immunomodulatory effects of vitamin D are also maximized at this threshold. 40,41 Moreover, to address any possible concerns about our chosen threshold, we also set thresholds at less than 20 ng/mL and less than 10 ng/mL, and the results were not materially different from what we reported for levels less than 30 ng/mL (data not shown). This relationship was further confirmed on the LOWESS analysis, which graphically represented a well-defined change in the relationship between vitamin D status and the risk for HAIs or SSIs at 25(OH)D levels less than 30 ng/mL vs 30 ng/mL or greater.…”
Section: Discussionmentioning
confidence: 91%
“…38 Although this traditional delineation is based on bone health–related studies demonstrating maximal parathyroid hormone suppression at 25(OH)D levels around 30 ng/mL, 39 some immunomodulatory effects of vitamin D are also maximized at this threshold. 40,41 Moreover, to address any possible concerns about our chosen threshold, we also set thresholds at less than 20 ng/mL and less than 10 ng/mL, and the results were not materially different from what we reported for levels less than 30 ng/mL (data not shown). This relationship was further confirmed on the LOWESS analysis, which graphically represented a well-defined change in the relationship between vitamin D status and the risk for HAIs or SSIs at 25(OH)D levels less than 30 ng/mL vs 30 ng/mL or greater.…”
Section: Discussionmentioning
confidence: 91%
“…In humans, cholecalciferol is either obtained through the diet or synthesized by skin upon exposure to ultraviolet B radiation [17]. Cholecalciferol is converted to 25OHD in the liver and then to 1,25OH2D by the kidneys and by cells of the immune system (amongst others) for paracrine use [37].…”
Section: Discussionmentioning
confidence: 99%
“…In humans, circulating 25-hydroxyvitamin D (25OHD) is the most abundant vitamin D metabolite [17]. As such, it is often used as a proxy for total body vitamin D status [18].…”
Section: Introductionmentioning
confidence: 99%
“…In order to maximize potential benefits and mitigate potential risks, supplementation of vitamin D to restore 25(OH) D levels within a range of 30-50 ng/ml is appropriate. This, of course, should be taken into account in the sense of the patient’s individual needs and co-morbidities [ 9 ] and the potential association between decreased mortality and post-fracture use of prescribed supplementation of calcium plus vitamin D and concomitant use of anti-osteoporotic drugs in females. Further investigations are required, however, in order to understand the reasons behind the reduction in the risk of death [ 10 ].…”
Section: Discussionmentioning
confidence: 99%